With new NIH funding, Najib El-Sayed is repurposing cancer-fighting inhibitors to block the metabolic “off-switch” Leishmania uses to hijack the immune system.
The grant will support the next phase of their project to improve the “smart pill” sensor design, ensuring the capsule captures reliable, real-time data on gut inflammation.
The new approach marks individual cells with light, allowing researchers to link a cell’s genetic makeup to its response during stimulation and behavior.
Katharina Maisel of the UMD Center of Excellence in Microbiome Sciences co-authored a study on a rare lung disease that progressively blocks oxygen flow.